112 related articles for article (PubMed ID: 11209086)
1. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.
Bruserud O; Gjertsen BT; Foss B; Huang TS
Stem Cells; 2001; 19(1):1-11. PubMed ID: 11209086
[TBL] [Abstract][Full Text] [Related]
2. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
3. New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.
Bruserud O; Gjertsen BT
Stem Cells; 2000; 18(3):157-65. PubMed ID: 10840068
[TBL] [Abstract][Full Text] [Related]
4. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
[TBL] [Abstract][Full Text] [Related]
5. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
7. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
Glenjen NI; Hatfield K; Bruserud Ø
Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
[TBL] [Abstract][Full Text] [Related]
8. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
9. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
10. In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines.
Bruserud O; Gjertsen BT; von Volkman HL
J Hematother Stem Cell Res; 2000 Dec; 9(6):923-32. PubMed ID: 11177606
[TBL] [Abstract][Full Text] [Related]
11. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
[TBL] [Abstract][Full Text] [Related]
12. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H
Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148
[TBL] [Abstract][Full Text] [Related]
13. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
Zhong RK; Lane TA; Ball ED
Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
[TBL] [Abstract][Full Text] [Related]
14. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
16. Platelet functions and clinical effects in acute myelogenous leukemia.
Foss B; Bruserud O
Thromb Haemost; 2008 Jan; 99(1):27-37. PubMed ID: 18217131
[TBL] [Abstract][Full Text] [Related]
17. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
18. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
[TBL] [Abstract][Full Text] [Related]
19. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities.
Bruserud Ø; Hovland R; Wergeland L; Huang TS; Gjertsen BT
Haematologica; 2003 Apr; 88(4):416-28. PubMed ID: 12681969
[TBL] [Abstract][Full Text] [Related]
20. Developmental approaches in immunological control of acute myelogenous leukaemia.
Torelli GF; Orsini E; Guarini A; Kell J; Foà R
Best Pract Res Clin Haematol; 2001 Mar; 14(1):189-209. PubMed ID: 11355931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
